Clinical Trial Update: A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) [Phase 3]

View source ↗

Summary

Daiichi Sankyo is conducting a Phase 3 trial to provide continued access to the study drug(s) and evaluate long-term safety in patients with advanced or metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Cancer, Metastatic Cancer | Phase 3 | Status: RECRUITING